Cargando…
Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta
Autores principales: | Rouby, Jean-Jacques, Zhu, Yinggang, Torres, Antoni, Rello, Jordi, Monsel, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576828/ https://www.ncbi.nlm.nih.gov/pubmed/36251177 http://dx.doi.org/10.1186/s13613-022-01068-8 |
Ejemplares similares
-
Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
por: Zhu, Yinggang, et al.
Publicado: (2021) -
Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020) -
Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020) -
FRI561 The Thyroid Trifecta
por: Kachhadia, Palak, et al.
Publicado: (2023) -
Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand
por: Ngamprasertchai, Thundon, et al.
Publicado: (2018)